{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:48:01Z","timestamp":1784645281605,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:00:00Z","timestamp":1435017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Egyptian Science and Technology Development Fund","doi-asserted-by":"crossref","award":["1512"],"award-info":[{"award-number":["1512"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00705-015-2493-0","type":"journal-article","created":{"date-parts":[[2015,6,21]],"date-time":"2015-06-21T22:28:14Z","timestamp":1434925694000},"page":"2181-2195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients"],"prefix":"10.1007","volume":"160","author":[{"given":"Nermin Abdel Hamid","family":"Sadik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat Gamil","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Zaki","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Akram","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Hamid Zaki","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,23]]},"reference":[{"key":"2493_CR1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jgh.12170","volume":"28","author":"J Howell","year":"2013","unstructured":"Howell J, Angus P, Gow P, Visvanathan K (2013) Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment. J Gastroenterol Hepatol 28:766\u2013776","journal-title":"J Gastroenterol Hepatol"},{"key":"2493_CR2","volume-title":"Egypt demographic and health survey 2008","author":"El-Zanaty Fatma","year":"2009","unstructured":"Fatma El-Zanaty, Ann Way (2009) Egypt demographic and health survey 2008. Ministry of Health, El-Zanaty and Associates, and Macro International, Cairo, Egypt"},{"issue":"2","key":"2493_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17(2):107\u2013115","journal-title":"Clin Microbiol Infect"},{"key":"2493_CR4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2010.11.016","volume":"54","author":"MA Khattab","year":"2011","unstructured":"Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL et al (2011) Management of hepatitis C virus genotype 4: recommendations of an international expert panel. J Hepatol 54:1250\u20131262","journal-title":"J Hepatol"},{"issue":"16","key":"2493_CR5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3748\/wjg.v19.i16.2529","volume":"19","author":"EMF Barakat","year":"2013","unstructured":"Barakat EMF, El Wakeel LM, Hagag RS (2013) Effects of Nigella sativa on outcome of hepatitis C in Egypt. J World Gastroenterol 19(16):2529\u20132536","journal-title":"J World Gastroenterol"},{"issue":"33","key":"2493_CR6","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1073\/pnas.1008877107","volume":"107","author":"FD Miller","year":"2010","unstructured":"Miller FD, Abu-Raddad LJ (2010) Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci 107(33):14757\u201314762","journal-title":"Proc Natl Acad Sci"},{"key":"2493_CR7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1471-2334-13-288","volume":"13","author":"YA Mohamoud","year":"2013","unstructured":"Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ (2013) The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 13:288","journal-title":"BMC Infect Dis"},{"issue":"9207","key":"2493_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","volume":"355","author":"C Frank","year":"2000","unstructured":"Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS et al (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355(9207):887\u2013891","journal-title":"Lancet"},{"issue":"5","key":"2493_CR9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21173","volume":"43","author":"GT Strickland","year":"2006","unstructured":"Strickland GT (2006) Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. J Hepatol 43(5):915\u2013922","journal-title":"J Hepatol"},{"key":"2493_CR10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. J Hepatol 49:1335\u20131374","journal-title":"J Hepatol"},{"key":"2493_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.dld.2009.08.001","volume":"42","author":"Italian Association for the study of the liver","year":"2010","unstructured":"Italian Association for the study of the liver, Italian Society of infectious td, Italian Society for the study of sexually transmitted diseases (2010) Practice guidelines for the treatment of hepatits C: recommendations from AISF\/ SIMIT\/SIMAST. Dig Liver Dis 42:81\u201391","journal-title":"Dig Liver Dis"},{"key":"2493_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0028-1110008","volume":"48","author":"C Sarrazin","year":"2010","unstructured":"Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U (2010) Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterol 48:289\u2013351","journal-title":"Z Gastroenterol"},{"key":"2493_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","volume":"55","author":"European Association for the Study of the Liver","year":"2011","unstructured":"European Association for the Study of the Liver (2011) EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 55:245\u2013264","journal-title":"J Hepatol"},{"key":"2493_CR14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.23985","volume":"53","author":"E Thomas","year":"2011","unstructured":"Thomas E, Feld JJ, Li Q, Hu Z, Fried MW (2011) Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. J Hepatol 53:32\u201341","journal-title":"J Hepatol"},{"key":"2493_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1743-422X-10-299","volume":"10","author":"M Imran","year":"2013","unstructured":"Imran M, Manzoor S, Ashraf J, Khalid M, Tariq M, Khaliq HM et al (2013) Role of viral and host factors in interferon based therapy of hepatitis C virus infection. J Virol 10:299","journal-title":"J Virol"},{"issue":"21","key":"2493_CR16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"JG McHutchison","year":"1998","unstructured":"McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK et al (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339(21):1485\u20131492","journal-title":"N Engl J Med"},{"key":"2493_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2000-9946","volume":"20","author":"B Rehermann","year":"2000","unstructured":"Rehermann B (2000) Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 20:127\u2013141","journal-title":"Semin Liver Dis"},{"key":"2493_CR18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nat 388:394\u2013397","journal-title":"Nat"},{"key":"2493_CR19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. J Hepatol 48:322\u2013335","journal-title":"J Hepatol"},{"key":"2493_CR20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.cellbio.21.122303.115827","volume":"22","author":"AP West","year":"2006","unstructured":"West AP, Koblansky AA, Ghosh S (2006) Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22:409\u2013437","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"2493_CR21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","volume":"13","author":"T Kawai","year":"2006","unstructured":"Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13(5):816\u2013825","journal-title":"Cell Death Differ"},{"key":"2493_CR22","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1172\/JCI26032","volume":"115","author":"AS Beignon","year":"2005","unstructured":"Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. Clin Invest 115:3265\u20133275","journal-title":"Clin Invest"},{"key":"2493_CR23","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","volume":"79","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Chisari FV (2005) Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79:9369\u20139380","journal-title":"J Virol"},{"key":"2493_CR24","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.3748\/wjg.v12.i30.4788","volume":"12","author":"YL He","year":"2006","unstructured":"He YL, Zhao YR, Zhang SL, Lin SM (2006) Host susceptibility to persistent hepatitis B virus infection. World Gastroenterol 12:4788\u20134793","journal-title":"World Gastroenterol"},{"key":"2493_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-3-21","volume":"3","author":"J Guo","year":"2010","unstructured":"Guo J, Friedman SL (2010) Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tiss Rep 3:21","journal-title":"Fibrogenesis Tiss Rep"},{"key":"2493_CR26","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1371\/journal.pone.0007803","volume":"11","author":"P Georgel","year":"2009","unstructured":"Georgel P, Macquin C, Bahram S (2009) The heterogeneous allelic repertoire of human Toll like receptors (TLR) genes. PLos One 11:7803","journal-title":"PLos One"},{"key":"2493_CR27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","volume":"406","author":"A Aderem","year":"2000","unstructured":"Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nat 406:782\u2013787","journal-title":"Nat"},{"key":"2493_CR28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA et al (2007) TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat Med 13:1324\u20131332","journal-title":"Nat Med"},{"key":"2493_CR29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/CS20070214","volume":"114","author":"EA Misch","year":"2008","unstructured":"Misch EA, Hawn TR (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci 114:347\u2013360","journal-title":"Clin Sci"},{"key":"2493_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000335606","volume":"82","author":"J Ag\u00fandez","year":"2012","unstructured":"Ag\u00fandez J, Garci-Martin E, Devesa M, Carballo M, Martnez C, Lee-Brunner A et al (2012) Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. J Oncol 82:35\u201340","journal-title":"J Oncol"},{"key":"2493_CR31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510240102","volume":"24","author":"TV Cacciarelli","year":"1996","unstructured":"Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM (1996) Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and post-treatment with interferon alfa. J Hepatol 24:6\u20139","journal-title":"J Hepatol"},{"key":"2493_CR32","first-page":"378","volume":"1","author":"HY Jia","year":"2002","unstructured":"Jia HY, Du J, Zhu SH et al (2002) The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 1:378\u2013382","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2493_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gene.6363645","volume":"1","author":"J Bidwell","year":"1999","unstructured":"Bidwell J, Keen L, Gallagher G et al (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1:3\u201319","journal-title":"Genes Immun"},{"key":"2493_CR34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1034\/j.1600-0676.2002.01553.x","volume":"22","author":"PK Constantini","year":"2002","unstructured":"Constantini PK, Wawrzynowicz-Syczewska M, Clare M et al (2002) Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver 22:404\u2013412","journal-title":"Liver"},{"key":"2493_CR35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0198-8859(03)00080-6","volume":"64","author":"D Lio","year":"2003","unstructured":"Lio D, Caruso C, Di Stefano R, Almasio et al (2003) IL-10 and TNF-a polymorphisms and the recovery from HCV infection. Hum Immunol 64:674\u2013680","journal-title":"Hum Immunol"},{"key":"2493_CR36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s005350170057","volume":"36","author":"S Sobue","year":"2001","unstructured":"Sobue S, Nomura T, Ishikawa T et al (2001) Th1\/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 36:544\u2013551","journal-title":"J Gastroenterol"},{"key":"2493_CR37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cyto.2012.10.013","volume":"61","author":"Ashim K Bagchi","year":"2013","unstructured":"Bagchi Ashim K, Sharma Anita et al (2013) Singal interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival. Cytokine 61:304\u2013314","journal-title":"Cytokine"},{"key":"2493_CR38","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.178.10.6173","volume":"178","author":"Y Yanagawa","year":"2007","unstructured":"Yanagawa Y, Ono\u00e9 K (2007) Enhanced IL-10 production by TLR4 and TLR2-primed dendritic cells upon restimulation. J Immunol 178:6173\u20136180","journal-title":"J Immunol"},{"key":"2493_CR39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696\u2013699","journal-title":"J Hepatol"},{"key":"2493_CR40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nature04078","volume":"436","author":"M Gale","year":"2005","unstructured":"Gale M, Foy EM (2005) Evasion of intracellular host defense by hepatitis C virus. Nat 436:939\u2013945","journal-title":"Nat"},{"key":"2493_CR41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1440-1746.2012.07273.x","volume":"27","author":"OG Shaker","year":"2012","unstructured":"Shaker OG, Sadik NAH (2012) Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon\/ribavirin-therapy. J Gastroenterol Hepatol 27:1842\u20131849","journal-title":"J Gastroenterol Hepatol"},{"key":"2493_CR42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/157016210791111052","volume":"8","author":"I Pulido","year":"2010","unstructured":"Pulido I, Leal M, Genebat M (2010) The TLR4 Asp2996Gly polymorphism is a risk factor for active tuberculosis in Cancasian HIV-infected patients. Curr HIV Res 8:253\u2013258","journal-title":"Curr HIV Res"},{"key":"2493_CR43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2008.07.006","volume":"49","author":"N Selzner","year":"2008","unstructured":"Selzner N, McGilvray I (2008) Can genetic variations predict HCV treatment outcomes? J Hepatol 49:494\u2013497","journal-title":"J Hepatol"},{"key":"2493_CR44","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1478-3231.2006.01357.x","volume":"26","author":"Q He","year":"2006","unstructured":"He Q, Graham CS, Durante ME, Koziel MJ (2006) Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C. Liver Internat 26:1100\u20131110","journal-title":"Liver Internat"},{"issue":"3","key":"2493_CR45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.25011\/cim.v31i3.3469","volume":"31","author":"X Wei","year":"2008","unstructured":"Wei X, Guo Y, Liu J, Wen Z, Yang S, Yao J (2008) The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B. Clin Invest Med 31(3):123\u2013130","journal-title":"Clin Invest Med"},{"key":"2493_CR46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.23481","volume":"85","author":"TNQ Pham","year":"2013","unstructured":"Pham TNQ, Lin DMH, Mulroone PM, Churchill ND, Piaskowska AK, Mozer-Lisewska I et al (2013) Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non-responders from responders to pegylated interferon alpha\u2013ribavirin treatment. Med Virol 85:441\u2013448","journal-title":"Med Virol"},{"key":"2493_CR47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499\u2013511","journal-title":"Nat Rev Immunol"},{"key":"2493_CR48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","volume":"413","author":"KA Fitzgerald","year":"2001","unstructured":"Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G et al (2001) Mal (MyD88-adapterlike) is required for Toll-like receptor-4 signal transduction. Nat 413:78\u201383","journal-title":"Nat"},{"key":"2493_CR49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ni986","volume":"4","author":"M Yamamoto","year":"2003","unstructured":"Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T et al (2003) TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4:1144\u20131150","journal-title":"Nat Immunol"},{"key":"2493_CR50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nature01889","volume":"424","author":"K Hoebe","year":"2003","unstructured":"Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S et al (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743\u2013748","journal-title":"Nature"},{"key":"2493_CR51","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","volume":"37","author":"YH Paik","year":"2003","unstructured":"Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. J Hepatol 37:1043\u20131055","journal-title":"J Hepatol"},{"key":"2493_CR52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1042\/bst0310664","volume":"31","author":"SN Vogel","year":"2003","unstructured":"Vogel SN, Fenton M (2003) Toll-like receptor 4 signalling: new perspectives on a complex signal-transduction problem. Biochem Soc Trans 31:664\u2013668","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"2493_CR53","first-page":"85","volume":"3","author":"P Christmas","year":"2010","unstructured":"Christmas P (2010) Toll-like receptors: sensors that detect infection. Nat Edu 3(9):85","journal-title":"Nat Edu"},{"key":"2493_CR54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.22697","volume":"49","author":"JS Guo","year":"2009","unstructured":"Guo JS, Zheng F, Hong F, Yea S, Fugita M, Tarocchi M et al (2009) Functional linkage of cirrhosis- predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. J Hepatol 49:960\u2013968","journal-title":"J Hepatol"},{"key":"2493_CR55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","volume":"430","author":"B Beutler","year":"2004","unstructured":"Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257\u2013263","journal-title":"Nature"},{"key":"2493_CR56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tox.2012.10.025","volume":"303","author":"H Shi","year":"2013","unstructured":"Shi H, Dong L, Jiang J, Zhao J, Zhao G, Dang X et al (2013) Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. J Toxicol 303:107\u2013114","journal-title":"J Toxicol"},{"issue":"9","key":"2493_CR57","first-page":"2957","volume":"56","author":"S Abdollahi-Roodsaz","year":"2007","unstructured":"Abdollahi-Roodsaz S, Joosten LAB, Roelofs MF, Radstake TRDJ, Giovanni Matera et al (2007) Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Am Coll Rheumatol 56(9):2957\u20132967","journal-title":"Am Coll Rheumatol"},{"key":"2493_CR58","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.coph.2012.06.002","volume":"12","author":"DJ Connolly","year":"2012","unstructured":"Connolly DJ, O\u2019Neill LAJ (2012) New developments in Toll-like receptor targeted therapeutics. Curr Opin Pharmacol 12:510\u2013518","journal-title":"Curr Opin Pharmacol"},{"key":"2493_CR59","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","volume":"50","author":"A Spruss","year":"2009","unstructured":"Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I (2009) Toll like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. J Hepatol 50:1094\u20131104","journal-title":"J Hepatol"},{"key":"2493_CR60","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","volume":"138","author":"S Thuy","year":"2008","unstructured":"Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Konigsrainer A et al (2008) Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138:1452\u20131455","journal-title":"J Nutr"},{"key":"2493_CR61","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","volume":"50","author":"P Mandrekar","year":"2009","unstructured":"Mandrekar P, Szabo G (2009) Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50:1258\u20131266","journal-title":"J Hepatol"},{"key":"2493_CR62","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jhep.2009.04.027","volume":"51","author":"Y Li","year":"2009","unstructured":"Li Y, Chang M, Abar O, Garcia V, Rowland C, Catanese J et al (2009) Multiple variants in Toll like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol 51:750\u2013757","journal-title":"J Hepatol"},{"key":"2493_CR63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2567.2009.03179.x","volume":"129","author":"J Wu","year":"2009","unstructured":"Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R et al (2009) Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. J Immunol 129:363\u2013374","journal-title":"J Immunol"},{"key":"2493_CR64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. J Physiol Rev 88:125\u2013172","journal-title":"J Physiol Rev"},{"key":"2493_CR65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1152\/ajpgi.2000.279.1.G7","volume":"279","author":"FJ Eng","year":"2000","unstructured":"Eng FJ, Friedman SL, Fibrogenesis I (2000) New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol 279:7\u201311","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2493_CR66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"issue":"48","key":"2493_CR67","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.3748\/wjg.v19.i48.9366","volume":"19","author":"MJ Wood","year":"2013","unstructured":"Wood MJ, Powell LW, Dixon JL, Subramaniam VN, Ramm GA (2013) Transforming growth factor-\u03b2 and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. World J Gastroenterol 19(48):9366\u20139376","journal-title":"World J Gastroenterol"},{"key":"2493_CR68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jmv.10472","volume":"71","author":"S Barrett","year":"2003","unstructured":"Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J (2003) Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol 71:212\u2013218","journal-title":"J Med Virol"},{"key":"2493_CR69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2893.2005.00634.x","volume":"12","author":"A Gramenzi","year":"2005","unstructured":"Gramenzi A, Andreone P, Loggi E et al (2005) Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepat 12:525\u2013530","journal-title":"J Viral Hepat"},{"key":"2493_CR70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.gene.6363920","volume":"3","author":"E Reuss","year":"2002","unstructured":"Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T (2002) Differential regulation of interleukin-10 production by genetic and environmental factors\u2014a twin study. Genes Immun 3:407\u2013413","journal-title":"Genes Immun"},{"key":"2493_CR71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/hep.1840190205","volume":"19","author":"C Ferrari","year":"1994","unstructured":"Ferrari C, Valli A, Galati L et al (1994) T-cell response to structural and nonstructural hepatitis C variants in persistent and self-limited hepatitis C virus infections. J Hepatol 19:286\u2013295","journal-title":"J Hepatol"},{"key":"2493_CR72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.510280332","volume":"28","author":"JJ Lasarte","year":"1998","unstructured":"Lasarte JJ, Garc\u00eda-Granero M, L\u00f3pez A et al (1998) Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. J Hepatol 28:815\u2013822","journal-title":"J Hepatol"},{"key":"2493_CR73","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","volume":"195","author":"FJ Barrat","year":"2002","unstructured":"Barrat FJ, Cua DJ, Boonstra A et al (2002) In vitro generation of interleukin 10-producing regulatory CD4 (1) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603\u2013616","journal-title":"J Exp Med"},{"key":"2493_CR74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-065X.1992.tb01414.x","volume":"127","author":"A Sher","year":"1992","unstructured":"Sher A, Gazzinelli RT, Oswald IP et al (1992) Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127:183\u2013204","journal-title":"Immunol Rev"},{"key":"2493_CR75","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","volume":"117","author":"JT Gerlach","year":"1999","unstructured":"Gerlach JT, Diepolder HM, Jung MC et al (1999) Recurrence of hepatitis C virus after loss of virus-specific CD4(1) T-cell response in acute hepatitis C. Gastroenterol 117:933\u2013941","journal-title":"Gastroenterol"},{"key":"2493_CR76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2478(00)00210-8","volume":"74","author":"M Sarih","year":"2000","unstructured":"Sarih M, Bouchrit N, Bebslimane A (2000) Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection. Immunol Lett 74:117\u2013120","journal-title":"Immunol Lett"},{"key":"2493_CR77","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.510300207","volume":"30","author":"CJ Edwards-Smith","year":"1999","unstructured":"Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. J Hepatol 30:526\u2013530","journal-title":"J Hepatol"},{"key":"2493_CR78","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1371\/journal.pone.0025009","volume":"6","author":"S Dhingra","year":"2011","unstructured":"Dhingra S, Bagchi AK, Ludke A, Sharma AK, Singal PK (2011) Akt regulates Il-10 mediated suppression of TNF-induced cardiomyocyte apoptosis by upregulating stat3 phosphorylation. PloS One 6:25009","journal-title":"PloS One"},{"key":"2493_CR79","first-page":"375","volume":"25","author":"K Honda","year":"2006","unstructured":"Honda K, Takaoka A, Taniguchi T (2006) Type 1 interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:375\u2013378","journal-title":"Immunity"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-015-2493-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2493-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T09:24:26Z","timestamp":1566897866000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-015-2493-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,23]]},"references-count":79,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["2493"],"URL":"https:\/\/doi.org\/10.1007\/s00705-015-2493-0","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,23]]}}}